Menu
Not yet recruiting NCT07739745

Development Of An Endometrial Cancer Educational Tool

No phase Interventional Endometrial Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Interactive Educational Website.
Who it may be relevant to
Registry conditions: Endometrial Cancer. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The goal of this study is to develop an online educational tool that we can make widely available to broader patient community.

Detailed description

Primary Objectives:

1. To develop an EC educational tool for systemic therapy of endometrial cancer. 2. To explore:

1. Acceptability of incorporating the EC educational tool into routine clinical care through a pilot study with EC patients 2. Feasibility, acceptability and the appropriateness of incorporating the EC educational tool into routine clinical care through a pilot study with health care providers of EC patients 3. To estimate the effectiveness of the EC educational tool with EC patients through a pilot study of EC patients and their health care providers.

Interventions

  • Other Interactive Educational Website
    Participants will utilize website to access educational content, knowledge measure, values survey, and cognitive and usability testing

Primary outcome measures

  • Safety and Adverse Events (AEs) [Time frame: Through study completion; an average of 1 year]

Eligibility criteria

Inclusion criteria

Patients:

Study Objective 1 (Part A-C see Figure 2)

  • Women who have been diagnosed with endometrial cancer
  • Must be at least 18 years old
  • Must read and speak English or Spanish
  • Must provide written informed consent

Study Objectives 2 and 3 (Pilot Study)

  • Women who have been diagnosed with endometrial cancer who are or will be receiving systemic treatment
  • Must be at least 18 years old
  • Must read and speak English or Spanish
  • Must provide written informed consent.

Physicians:

Study Objective 1 (Qualitative Interviews)

  • Gynecologic oncologists or medical oncologists who practice at MDA or outside institutions
  • Must be able to speak and read English
  • Must provide written informed consent

Healthcare Providers:

Study Objectives 2 and 3 (Pilot Study)

  • Healthcare Providers (including but not limited to gynecologic oncologists and APPs) who practice at MDA, the HALs or LBJ Hospital who provide care to women diagnosed with endometrial cancer
  • Must be able to speak and read English
  • Must provide written informed consent

Exclusion criteria

None

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

United States · 1 center
  • UT MD Anderson — Houston

Identifiers

NCT: NCT07739745 · 2025-0421 · NCI-2026-05749

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗